BIOMAT Database Logo BIOMAT Database Logo

Activation of GABAA receptor in the brain suppresses neostigmine or histamine-induced central nervous system-mediated hyperglycemia. 1993

K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.

We investigated the effect of GABA receptor agonists on the central nervous system (CNS)-mediated hyperglycemia induced by neostigmine or histamine in anesthetized fed rats. The injection of muscimol, GABAA receptor agonist (1, 2.5 nmol) into the third cerebral ventricle suppressed the hyperglycemia induced by intraventricular injection of neostigmine (1 x 10(-8) mol) or histamine (5 x 10(-7) mol). Baclofen, GABAB receptor agonist (1, 2.5 nmol), however, did not suppress these hyperglycemia. Neither muscimol nor baclofen (2.5 nmol) affected plasma glucose levels. These findings suggest that activation of GABAA receptor in the CNS suppresses the hyperglycemia induced by the stimulation of cholinoceptive neuron or histaminergic neuron, but activation of GABAB receptor does not affect them.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D009118 Muscimol A neurotoxic isoxazole isolated from species of AMANITA. It is obtained by decarboxylation of IBOTENIC ACID. Muscimol is a potent agonist of GABA-A RECEPTORS and is used mainly as an experimental tool in animal and tissue studies. Agarin,Pantherine
D009388 Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. Synstigmin,Neostigmine Bromide,Neostigmine Methylsulfate,Polstigmine,Proserine,Prostigmin,Prostigmine,Prozerin,Syntostigmine,Bromide, Neostigmine,Methylsulfate, Neostigmine
D011963 Receptors, GABA-A Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop. Benzodiazepine-Gaba Receptors,GABA-A Receptors,Receptors, Benzodiazepine,Receptors, Benzodiazepine-GABA,Receptors, Diazepam,Receptors, GABA-Benzodiazepine,Receptors, Muscimol,Benzodiazepine Receptor,Benzodiazepine Receptors,Benzodiazepine-GABA Receptor,Diazepam Receptor,Diazepam Receptors,GABA(A) Receptor,GABA-A Receptor,GABA-A Receptor alpha Subunit,GABA-A Receptor beta Subunit,GABA-A Receptor delta Subunit,GABA-A Receptor epsilon Subunit,GABA-A Receptor gamma Subunit,GABA-A Receptor rho Subunit,GABA-Benzodiazepine Receptor,GABA-Benzodiazepine Receptors,Muscimol Receptor,Muscimol Receptors,delta Subunit, GABA-A Receptor,epsilon Subunit, GABA-A Receptor,gamma-Aminobutyric Acid Subtype A Receptors,Benzodiazepine GABA Receptor,Benzodiazepine Gaba Receptors,GABA A Receptor,GABA A Receptor alpha Subunit,GABA A Receptor beta Subunit,GABA A Receptor delta Subunit,GABA A Receptor epsilon Subunit,GABA A Receptor gamma Subunit,GABA A Receptor rho Subunit,GABA A Receptors,GABA Benzodiazepine Receptor,GABA Benzodiazepine Receptors,Receptor, Benzodiazepine,Receptor, Benzodiazepine-GABA,Receptor, Diazepam,Receptor, GABA-A,Receptor, GABA-Benzodiazepine,Receptor, Muscimol,Receptors, Benzodiazepine GABA,Receptors, GABA A,Receptors, GABA Benzodiazepine,delta Subunit, GABA A Receptor,epsilon Subunit, GABA A Receptor,gamma Aminobutyric Acid Subtype A Receptors
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias

Related Publications

K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
Activation of central GABAA receptors suppresses the alteration of plasma catecholamine levels induced by neostigmine or histamine in rats.
January 1994, Life sciences,
K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
Neostigmine-induced hyperglycemia is mediated by central muscarinic receptor in fed rats.
January 1990, Brain research,
K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
Ethanol-induced hyperglycemia mediated by the central nervous system.
January 1983, Pharmacology, biochemistry, and behavior,
K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
Role of the Histamine H3 Receptor in the Central Nervous System.
January 2017, Handbook of experimental pharmacology,
K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
GABAA and GABAB receptor site distribution in the rat central nervous system.
February 1987, Neuroscience,
K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
Histamine in the central nervous system.
January 1978, Proceedings of the Western Pharmacology Society,
K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
Somatostatin-induced histamine response in the rat central nervous system.
August 1987, The Tohoku journal of experimental medicine,
K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
Regulation of GABAA receptor function and gene expression in the central nervous system.
January 1995, International review of neurobiology,
K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
Central nervous system reactions to histamine-2 receptor blockers.
June 1991, Annals of internal medicine,
K Nonogaki, and X Li, and K Ozawa, and H Miura, and G Watanabe, and Y Hiyoshi, and T Tamagawa, and N Sakamoto, and A Iguchi
Pleiotropic effect of histamine H4 receptor modulation in the central nervous system.
August 2013, Neuropharmacology,
Copied contents to your clipboard!